S
Stephanie P Schwartz
Researcher at University of North Carolina at Chapel Hill
Publications - 39
Citations - 1779
Stephanie P Schwartz is an academic researcher from University of North Carolina at Chapel Hill. The author has contributed to research in topics: Medicine & Internal medicine. The author has an hindex of 7, co-authored 20 publications receiving 324 citations. Previous affiliations of Stephanie P Schwartz include Duke University & Boston Children's Hospital.
Papers
More filters
Journal ArticleDOI
Characteristics and Outcomes of US Children and Adolescents With Multisystem Inflammatory Syndrome in Children (MIS-C) Compared With Severe Acute COVID-19.
Leora R. Feldstein,Leora R. Feldstein,Mark W Tenforde,Kevin G. Friedman,Margaret M Newhams,Erica Billig Rose,Erica Billig Rose,Heda Dapul,Vijaya L. Soma,Aline B Maddux,Peter M. Mourani,Cindy Bowens,Mia Maamari,Mark W. Hall,Becky J. Riggs,John S. Giuliano,Aalok R. Singh,Simon Li,Michele Kong,Jennifer E. Schuster,Gwenn E. McLaughlin,Stephanie P Schwartz,Tracie C. Walker,Laura Loftis,Charlotte V. Hobbs,Natasha B. Halasa,Sule Doymaz,Christopher Babbitt,Janet R. Hume,Shira J. Gertz,Katherine Irby,Katharine N. Clouser,Natalie Z. Cvijanovich,Tamara T. Bradford,Lincoln S. Smith,Sabrina M. Heidemann,Sheemon P. Zackai,Kari Wellnitz,Ryan Nofziger,Steven M. Horwitz,Ryan W. Carroll,Courtney M. Rowan,Keiko M. Tarquinio,Elizabeth H. Mack,Julie C. Fitzgerald,Bria M. Coates,Ashley M. Jackson,Cameron C. Young,Mary Beth F. Son,Manish M. Patel,Manish M. Patel,Jane W. Newburger,Adrienne G. Randolph +52 more
TL;DR: In this article, the authors compared clinical characteristics and outcomes of children and adolescents with MIS-C vs those with severe coronavirus disease 2019 (COVID-19) at 66 US hospitals in 31 states.
Journal ArticleDOI
Effectiveness of BNT162b2 (Pfizer-BioNTech) mRNA Vaccination Against Multisystem Inflammatory Syndrome in Children Among Persons Aged 12–18 Years — United States, July–December 2021
Laura D. Zambrano,Margaret M Newhams,Samantha M. Olson,Natasha B. Halasa,Ashley M. Price,Julie A. Boom,Leila C. Sahni,Satoshi Kamidani,Keiko M. Tarquinio,Aline B Maddux,Sabrina M. Heidemann,Samina Bhumbra,Katherine Bline,Ryan Nofziger,Charlotte V. Hobbs,Tamara T. Bradford,Natalie Z. Cvijanovich,Katherine Irby,Elizabeth H. Mack,Melissa Cullimore,Pia S. Pannaraj,Michele Kong,Tracie C. Walker,Shira J. Gertz,Kelly Michelson,Melissa A. Cameron,Kathleen Chiotos,Mia Maamari,Jennifer E. Schuster,Amber O. Orzel,Manish M. Patel,Angela P Campbell,Adrienne G. Randolph,Meghan Murdock,Mary Glas Gaspers,Katri V. Typpo,Connor P Kelley,Ronald C. Sanders,M. Yates,Chelsea R. Smith,Katheryn L. Crane,Geraldina Lionetti,Juliana Murcia-Montoya,Matt S. Zinter,Denise Villarreal-Chico,Adam Skura,Harvey Peralta,Justin Lockwood,Emily Port,Imogene A Carson,Brandon Chatani,Laila Hussaini,N.K. Baida,Bria M. Coates,Courtney M. Rowan,M Stumpf,Marla Johnston,Benjamin J. Boutselis,Suden Kucukak,Sabrina R. Chen,Edie Weller,Laura Berbert,Jie He,Heidi R. Flori,Janet R. Hume,Ella Bruno,Lexie Goertzen,Emily R Levy,Supriya Behl,Noelle M. Drapeau,Lora Lee Martin,Lacy Malloch,Cameron Sanders,Kayla Patterson,Anita Dhanrajani,Shannon M. Hill,Abigail Kietzman,Valerie H. Rinehart,Lauren A. Hoody,Stephanie P Schwartz,A. Navas,Paris C. Bennett,Nicole Twinem,Merry L. Tomcany,Mary A. Staat,Chelsea C. Rohlfs,Amber Wolfe,Rebecca L. Douglas,Kathlyn Phengchomphet,Megan M. Bickford,Lauren Wakefield,L S Smallcomb,Laura S Stewart,Meenakshi Golchha,Jennifer N. Oates,Cindy Bowens +95 more
TL;DR: Receipt of 2 doses of the Pfizer-BioNTech vaccine is associated with a high level of protection against MIS-C in persons aged 12-18 years, highlighting the importance of vaccination among all eligible children.
Journal ArticleDOI
Multisystem Inflammatory Syndrome in Children - Initial Therapy and Outcomes.
Mary Beth F. Son,Nancy Murray,Kevin G. Friedman,Cameron C. Young,Margaret M. Newhams,Leora R. Feldstein,Laura L. Loftis,Keiko M. Tarquinio,Aalok R. Singh,Sabrina M. Heidemann,Vijaya L. Soma,Becky J. Riggs,Julie C. Fitzgerald,Michele Kong,Sule Doymaz,John S. Giuliano,Michael A. Keenaghan,Janet R. Hume,Charlotte V. Hobbs,Jennifer E. Schuster,Katharine N. Clouser,Mark W. Hall,Lincoln S. Smith,Steven M. Horwitz,Stephanie P Schwartz,Katherine Irby,Tamara T. Bradford,Aline B Maddux,Christopher J. Babbitt,Courtney M. Rowan,Gwenn E. McLaughlin,Phoebe H. Yager,Mia Maamari,Elizabeth H. Mack,Christopher L. Carroll,Vicki L. Montgomery,Natasha B. Halasa,Natalie Z. Cvijanovich,Bria M. Coates,Charles E. Rose,Jane W. Newburger,Manish M. Patel,Adrienne G. Randolph +42 more
TL;DR: In this article, the assessment of real-world effectiveness of immunomodulatory medications for multisystem inflammatory syndrome in children (MIS-C) may guide therapy, and the authors analyzed surve...
Journal ArticleDOI
Effectiveness of Maternal Vaccination with mRNA COVID-19 Vaccine During Pregnancy Against COVID-19–Associated Hospitalization in Infants Aged <6 Months — 17 States, July 2021–January 2022
Natasha B. Halasa,Samantha M. Olson,Mary A. Staat,Margaret M Newhams,Ashley M. Price,Julie A. Boom,Leila C. Sahni,Melissa A. Cameron,Pia S. Pannaraj,Katherine Bline,Samina Bhumbra,Tamara T. Bradford,Kathleen Chiotos,Bria M. Coates,Melissa Cullimore,Natalie Z. Cvijanovich,Heidi R. Flori,Shira J. Gertz,Sabrina M. Heidemann,Charlotte V. Hobbs,Janet R. Hume,Katherine Irby,Satoshi Kamidani,Michele Kong,Emily R Levy,Elizabeth H. Mack,Aline B Maddux,Kelly Michelson,Ryan Nofziger,Jennifer E. Schuster,Stephanie P Schwartz,L S Smallcomb,Keiko M. Tarquinio,Tracie C. Walker,Matt S. Zinter,Suzanne M. Gilboa,Kara N. D. Polen,Angela P Campbell,Adrienne G. Randolph,Manish M. Patel,Laura D. Zambrano,Meghan Murdock,Mary Glas Gaspers,Connor P Kelley,Katri V. Typpo,Peter M. Mourani,Ronald C. Sanders,Charanne P. Smith,M. Yates,Katheryn L. Crane,Geraldina Lionetti,Juliana Murcia-Montoya,Denise Villarreal-Chico,Daniel Hakimi,Adam Skura,Imogene A Carson,Justin Lockwood,Emily Port,Brandon Chatani,N.K. Baida,Laila Hussaini,Hassan A. Khan,Simone T. Rhodes,Courtney M. Rowan,M Stumpf,Marla Johnston,Laura Berbert,Benjamin J. Boutselis,Sabrina R. Chen,Jie He,Suden Kucukak,Timothy P. McCadden,Amber O. Orzel,Edie Weller,Patrick Moran,Ella Bruno,Lexie Goertzen,Supriya Behl,Noelle M. Drapeau,Lacy Malloch,Lora M Martin,April Palmer,Roberto P. Santos,Abigail Kietzman,Melissa Sullivan,Lauren A. Hoody,Valerie H. Rinehart,Paris C. Bennett,Merry L. Tomcany,Nicole Twinem,Chelsea C. Rohlfs,Amber Wolfe,Rebecca L. Douglas,Kathlyn Phengchomphet,Megan M. Bickford,Lauren Wakefield,Meenakshi Golchha,Laura S Stewart,Jennifer N. Oates,Cindy Bowens,Mia Maamari +100 more
TL;DR: Effectiveness of maternal vaccination during pregnancy against COVID-19 hospitalization in infants aged <6 months was 61% (95% CI = 31%-78%).
Journal ArticleDOI
BNT162b2 Protection against the Omicron Variant in Children and Adolescents
Ashley M. Price,Samantha M. Olson,Margaret M Newhams,Natasha B. Halasa,Julie A. Boom,Leila C. Sahni,Pia S. Pannaraj,Katherine Irby,Katherine Bline,Aline B Maddux,Ryan Nofziger,Melissa A. Cameron,Tracie C. Walker,Stephanie P Schwartz,Elizabeth H. Mack,L S Smallcomb,Jennifer E. Schuster,Charlotte V. Hobbs,Satoshi Kamidani,Keiko M. Tarquinio,Tamara T. Bradford,Emily R Levy,Kathleen Chiotos,Samina Bhumbra,Natalie Z. Cvijanovich,Sabrina M. Heidemann,Melissa Cullimore,Shira J. Gertz,Bria M. Coates,Mary A. Staat,Matt S. Zinter,Michele Kong,Brandon Chatani,Janet R. Hume,Katri V. Typpo,Mia Maamari,Heidi R. Flori,Mark W Tenforde,Laura D. Zambrano,Angela P Campbell,Manish M. Patel,Adrienne G. Randolph +41 more
TL;DR: BNT162b2 vaccination reduced the risk of omicron-associated hospitalization by two thirds among children 5 to 11 years of age and against noncritical Covid-19, and prevented critical illness caused by either variant.